The purpose of this study is to examine the short- and long-term efficacy of botulinum toxin type-A (BOTOX®, Allergan, Inc.) in treating pain caused by damage to a nerve. Participants will receive either Btx-A or placebo (sterile saline injection).
Males and females, 18-90 years of age with neuroma pain.
All participants will have a medical history and physical exam, complete questionnaires about pain and quality of life, receive a digit transcutaneous oxygen saturation test (non-invasive measurement of the oxygen level in the blood), have imaging to confirm the diagnosis if necessary, and attend follow-up appointments. Participants will be randomized and given either BOTOX® or a placebo (saline) at the first appointment.
The study is a long-term follow-up study in which the participants will be contacted several times over 5 years to see how long the effects of BOTOX® injection(s) last.
Please contact Jennifer Koechle, MPH, at (217) 545-7014 or email email@example.com .
Michael W. Neumeister, MD